earnings
confidence high
sentiment positive
materiality 0.65
Revvity provides preliminary Q4 revenue ~$730M, 6% organic growth; EPS guidance reaffirmed
REVVITY, INC.
2024-FY EPS reported
$2.20
revenue$2,755,026,000
- Q4 preliminary revenue ~$730M; reported growth ~5%, organic ~6% vs. prior year.
- Full-year 2024 adjusted EPS expected to meet or exceed guidance provided Nov 4, 2024.
- Q4 and full-year 2024 results to be released Jan 31, 2025; conference call at 8am ET.
- CEO Prahlad Singh to present at J.P. Morgan Healthcare Conference on Jan 13, 2025.